FDA NCTR On-Site Pathology Services
ID: 75F40125R00059_PresolicitationType: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

All Other Professional, Scientific, and Technical Services (541990)

PSC

MEDICAL- PATHOLOGY (Q515)

Original Source

https://sam.gov/opp/a07d249b0dec486fbaf5688e183aedd7/view
Timeline
    Description

    The U.S. Food and Drug Administration (FDA) is preparing to solicit comprehensive on-site animal pathology services for its National Center for Toxicological Research (NCTR) to support its research programs aimed at public health protection. The required services will encompass a variety of pathology support tasks, including necropsies, histopathology, and specialized techniques such as immunohistochemistry and respiratory pathology, as dictated by research protocols from Principal Investigators. This opportunity is significant for businesses in the professional, scientific, and technical services sector, with the solicitation number 75F40125R00059 expected to be released around April 30, 2025, and a closing date set for 30 days post-release. Interested parties should monitor SAM.gov for updates and can contact Tim Walbert at timothy.walbert@fda.hhs.gov or 870-543-7267 for further information.

    Point(s) of Contact
    Tim Walbert
    (870) 543-7267
    timothy.walbert@fda.hhs.gov
    Files
    Title
    Posted
    Presolicitation Notice - FDA NCTR Pathology Services.pdf
    The U.S. Food and Drug Administration (FDA) is preparing to solicit comprehensive on-site animal pathology services for its National Center for Toxicological Research (NCTR) to support its research programs aimed at public health protection. The services required will involve a range of pathology support tasks as dictated by research protocols from Principal Investigators, including necropsies, histopathology, and various specialized techniques such as immunohistochemistry and respiratory pathology. This opportunity is open to all businesses, as the solicitation will be conducted under full and open competition, with a small business size standard of $19.5 million associated with the NAICS code 541990. The solicitation number 75F40125R00059 is scheduled for release around April 30, 2025, with a closing date of 30 days post-release. The resulting contract is expected to be structured as a Labor Hour contract, including a base year and up to four optional years. Interested parties must monitor SAM.gov for updates on this solicitation.
    Lifecycle
    Title
    Type
    FDA NCTR On-Site Pathology Services
    Currently viewing
    Presolicitation
    Similar Opportunities
    Digital Slide Scanner System
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking to acquire a Digital Slide Scanner System for the National Center for Toxicological Research (NCTR) to replace outdated equipment in its Pathology Lab. The new scanner must be capable of scanning at 20X and 40X magnifications, support brightfield and fluorescent imaging, and include features such as barcode scanning, z-stack capability, and image analysis software, while ensuring compliance with FedRAMP and FISMA standards. This system is crucial for creating digital copies of glass slides for research sharing and publications, as well as for providing quantitative data analysis. Interested vendors should note that responses are due by December 18, 2025, and can contact David Kramer at david.kramer@fda.hhs.gov or Nick Sartain at nick.sartain@fda.hhs.gov for further information.
    Support for Evaluating and Conducting Computational and Alternative Toxicological Methods for the National Institute of Environmental Health Sciences
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institute of Environmental Health Sciences (NIEHS), is seeking proposals from small businesses to support the evaluation and conduct of computational and alternative toxicological methods. The objective of this procurement is to assist NIEHS in chemical hazard and risk assessment while minimizing the use of animal testing, focusing on areas such as population variability, developmental neurotoxicity, and carcinogenicity. This contract, which is a Cost-Plus-Fixed-Fee type, has a base period of performance from June 1, 2026, to May 31, 2027, with nine additional one-year options and a potential six-month extension. Proposals are due by December 19, 2025, and must be submitted electronically via the NIH eCPS website; interested parties can contact Jason Williams at jason.williams2@nih.gov or Lisa Schaupp at lisa.schaupp@nih.gov for further information.
    FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY26 Broad Agency Announcement (BAA) for advanced research and development in regulatory science. This opportunity aims to acquire basic and applied research that supports regulatory science and innovation, focusing on areas such as New Approach Methodologies, Advanced Manufacturing, and Clinical Outcome Assessments, among others. The FDA's initiative is crucial for enhancing scientific knowledge that aids in protecting and promoting public health, particularly for underrepresented populations and in reducing animal testing. Interested parties, including small businesses and academic institutions, are encouraged to submit proposals by February 24, 2026, and can reach out to Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    FDA BIMO Inspections and Compliance Support
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is conducting a Sources Sought notice to identify small businesses capable of providing professional services for its Bio-Research Monitoring (BIMO) program. The FDA aims to modernize and consolidate its IT systems to enhance inspections and compliance support, requiring expertise in areas such as workflow management, data integration, and the development of a centralized BIMO database and analytics platform. This initiative is critical for improving the efficiency and effectiveness of BIMO inspections across all centers, and interested parties must submit their responses by January 5, 2026, to Michelle Dacanay at michelle.dacanay@fda.hhs.gov.
    Operation and Maintenance of a Murine Pathogen-Free Mouse Breeding Facility
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking contractors for the operation and maintenance of a Murine Pathogen-Free Mouse Breeding Facility. This procurement aims to ensure the facility operates efficiently, providing essential support for research involving pathogen-free mice, which are critical for various biomedical studies. The contract will be managed under the PSC code R707, indicating a focus on management and support services. Interested parties can reach out to Sevag Kasparian at Sevag.Kasparian@nih.gov or 240-669-5177, or Gabriel Contreras at gabriel.contreras@nih.gov or 240-292-4828 for further details regarding the opportunity.
    Irradiated Sani-chip Bedding
    Health And Human Services, Department Of
    The Food and Drug Administration (FDA) is seeking sources for irradiated Sani-chip bedding to be used in housing animal species, primarily rodents, at the National Center for Toxicological Research (NCTR) in Jefferson, Arkansas. The procurement aims to acquire heat-treated, cube-cut hardwood chip bedding that meets specific sanitation, animal well-being, and thermoregulation requirements, including being free of contaminants and irradiated to a minimum dose of 15 kGy. This bedding is crucial for maintaining a clean and healthy environment for research animals, facilitating their natural behaviors and overall welfare. Interested vendors must submit their responses, including company information and past performance, by December 15, 2025, to David Kramer at david.kramer@fda.hhs.gov, as this opportunity is part of market research and not a formal solicitation.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to the diagnosis, prevention, or treatment of diseases. The procurement aims to establish contracts for domestic delivery of medical laboratory services, ensuring compliance with all relevant state, federal, and local regulations, including necessary licenses and permits for testing services. This opportunity is critical for enhancing patient care through accurate diagnostic testing, with the expectation that offerors will provide new items only, adhering to FDA regulatory requirements. Interested vendors can contact the FSS Help Desk at Fss.Help@va.gov or call 708-786-7737 for further details, as the solicitation is currently pending and specific deadlines for proposal submissions will be outlined in the official solicitation documents.
    6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Thyroid Cancer Molecular Tests for the Orlando VA Healthcare System and Caribbean VA Healthcare System through a Firm-Fixed Price (FFP) contract. This procurement is designated as a Service-Disabled Veteran-Owned Small Business (SDVOSBC) set-aside, with the NAICS code 621511 and a small business size standard of $41.5 million. The solicitation is expected to be posted on sam.gov around December 15, 2025, with a response deadline of December 29, 2025, at 4:00 PM Eastern Time. Interested offerors must be registered in the System for Award Management (SAM) to be eligible for award, and for further inquiries, they can contact Yolanda Glover at yolanda.glover@va.gov or by phone at 352-381-5712.
    Q301--Metabolomics and Lipidomics Pulmonary Study
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for a Metabolomics and Lipidomics Pulmonary Study, focusing on the analysis of 185 human samples. This contract, designated for Small Businesses under NAICS code 541714, aims to enhance understanding of pulmonary conditions through advanced biochemical analysis. The performance period for the contract is set from December 31, 2025, to December 30, 2026, with proposals due by December 15, 2025, at 10:00 AM MST. Interested vendors should direct inquiries to Contract Specialist Felicia L. Simpson at felicia.simpson@va.gov and ensure compliance with all registration and documentation requirements to facilitate timely processing.
    NFPC Lab testing IDIQ 3 years
    Dept Of Defense
    The Department of Defense, through the Naval Surface Warfare Center Philadelphia Division (NSWCPD), is seeking proposals for a three-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract for non-destructive testing (NDT) services. The contract will cover a variety of lab testing services, including chemical analysis, microstructure analysis, and fluorescent penetrant inspection, among others, with a maximum order value of $520,265.29. This procurement is crucial for ensuring the integrity and safety of ship and marine equipment, which is vital for national defense operations. Interested vendors must submit their quotes by December 17, 2025, at 3:00 PM local time, via email to Jessica Kelley at jessica.m.kelley23.civ@us.navy.mil, and must be registered in the System for Award Management (SAM).